Cogent Biosciences Inc (NASDAQ:COGT) price on Thursday, May 01, rose 8.06% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $5.63.
A look at the stock’s price movement, the close in the last trading session was $5.21, moving within a range at $5.055 and $5.64. The beta value (5-Year monthly) was 0.196. Turning to its 52-week performance, $12.61 and $3.72 were the 52-week high and 52-week low respectively. Overall, COGT moved -2.76% over the past month.
Cogent Biosciences Inc’s market cap currently stands at around $641.01 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Feb-24.
Turning to the stock’s technical picture we see that short term indicators suggest on average that COGT is a 50% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
4 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 4 recommend COGT as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
COGT’s current price about 21.49% and -7.60% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 56.30, while 7-day volatility ratio is 8.07% and 10.21% in the 30-day chart. Further, Cogent Biosciences Inc (COGT) has a beta value of 1.92, and an average true range (ATR) of 0.43. Analysts have given the company’s stock an average 52-week price target of $14, forecast between a low of $14 and high of $14. Looking at the price targets, the low is -148.67% off current price level while to achieve the yearly target high, price needs to move -148.67%. Nonetheless, investors will most likely welcome a -148.67% jump to $14 which is the analysts’ median price.
If we refocus on Cogent Biosciences Inc (NASDAQ:COGT), historical trading data shows that trading volumes averaged 1.23 over the past 10 days and 1.38 million over the past 3 months. The company’s latest data on shares outstanding shows there are 110.46 million shares.
The 16.22% of Cogent Biosciences Inc’s shares are in the hands of company insiders while institutional holders own 91.52% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 14.33 million on 2025-04-15, giving us a short ratio of 9.34. The data shows that as of 2025-04-15 short interest in Cogent Biosciences Inc (COGT) stood at 1473.9999 of shares outstanding, with shares short rising to 11.84 million registered in 2025-03-14. Current price change has pushed the stock -27.82% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the COGT stock continues to rise going into the next quarter.
